Stéphane Champiat, Associate Professor at MD Anderson Cancer Center, shared a post on LinkedIn:
“Targeting TRegs for Cancer Immunotherapy.
Delighted to share our latest review in Annals of Oncology !
It’s the right time to deepen your knowledge of Treg biology, better define their role in cancer, and learn about the most promising therapeutic approaches emerging in the field.
Congratulations to Oriol Mirallas and all co-authors on this collaborative effort.”
Title: Targeting Regulatory T Cells for Cancer Immunotherapy: Promises and Pitfalls
Authors: O. Mirallas, G. Pretelli, M. Balsa, P. Jiménez-Labaig, A. Hernando-Calvo, H. Nathan Tan, P. Selvadurai, P. Tallón de Lara, M. Vieito, J. Martin-Liberal, K.J. Harrington, S. Champiat, E. Garralda
Read The Full Article
Other articles about Immunotherapy on OncoDaily.